Wellmarker Bio

Developer of biomarker-based therapeutics for the treatment of cancer

placeSeoul, Seoul, South Korea calendar_todayFounded 2016 groups58 employees language wmbio.co

Registered entities

Innovation

24 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 333 times.

YearFilings
20181
20192
20205
202114
20226
202313
20248
20251

Investor mix

21 investors on record; lead investors include Orbit Partners, bric-investment.com, NH Investment & Securities, Cytogen.

Investor typeCountShare
Venture capital733%
Private equity314%
Accelerator & incubator210%
Bank & private debt210%
Other / undisclosed733%
Coming soon